Paeds SAQs · genetics-dysmorphology-and-metabolism
Syndromic craniosynostosis and craniofacial disorders — formative SAQs
Formative SAQs on syndromic craniosynostosis: recognising the head-face-limb fingerprint that earns the syndromic label, naming the big six by gene, confirming the diagnosis with imaging and targeted genetic testing, securing the airway, the exposed eye and raised intracranial pressure before any cosmetic plan, and coordinating an age-based craniofacial team.
On this page & tools
Target exams
SAQ 1 (10)
A three-month-old infant presents with a tall, tower-shaped head, marked exorbitism with bilateral corneal exposure, midface hypoplasia, and severe symmetric syndactyly of all four limbs producing a mitten hand. The baby snores loudly and feeds slowly, crossing weight centiles downward. [6] [7]
a) What is the most likely diagnosis and its gene? Give the one-line problem representation that justifies the syndromic label. (2 marks) [1]
b) Outline the immediate resuscitation priorities, naming the three things that must be secured before any cosmetic vault surgery and the specific intervention for each. (4 marks) [3] [7]
c) Describe the investigation plan: the imaging that maps every fused suture and the brain, the airway investigation, the ophthalmology assessment, and the genetic test that confirms the gene. (2 marks) [1] [6]
d) State the inheritance and the recurrence risk for the next pregnancy, and the implication for parental testing. (2 marks) [6]
SAQ 2 (10)
A two-year-old was labelled with nonsyndromic right unicoronal craniosynostosis and had an endoscopic strip craniectomy at five months. She re-presents with recurrent coronal fusion needing reoperation, a broad, short medially-deviated right great toe, and newly diagnosed sensorineural hearing loss. [12] [1]
a) What is the most likely unrecognised diagnosis, its gene and recurrent variant, and why is it so often mistaken for nonsyndromic disease? (3 marks) [12]
b) What does the evidence show about this variant and the risk of reoperation, and what is the safeguard test that should have been sent at diagnosis? (2 marks) [12]
c) Outline the surveillance this child should now receive across airway, hearing, intracranial pressure and development, and explain why each matters. (3 marks) [7] [9]
d) The parents ask whether a future child could be affected. State the recurrence risk, the prenatal options, and the counselling about mildly affected family members. (2 marks) [6] [12]
References
- [1]Twigg SR, Wilkie AO. New insights into craniofacial malformations. Hum Mol Genet, 2015.PMID 26085576
- [3]Kreiborg S, Cohen MM Jr. Ocular manifestations of Apert and Crouzon syndromes: qualitative and quantitative findings. J Craniofac Surg, 2010.PMID 20856021
- [6]Passos-Bueno MR, Wilcox WR, Jabs EW, et al. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat, 1999.PMID 10425034
- [7]Fernandes MB, Maximino LP, Perosa GB, et al. Apert and Crouzon syndromes-Cognitive development, brain abnormalities, and molecular aspects. Am J Med Genet A, 2016.PMID 27028366
- [9]Wenger TL, Hopper RA, Rosen A, et al. A genotype-specific surgical approach for patients with Pfeiffer syndrome due to W290C pathogenic variant in FGFR2 is associated with improved developmental outcomes and reduced mortality. Genet Med, 2019.PMID 29915381
- [12]Thomas GP, Wilkie AO, Richards PG, Wall SA. FGFR3 P250R mutation increases the risk of reoperation in apparent 'nonsyndromic' coronal craniosynostosis. J Craniofac Surg, 2005.PMID 15915095